Able-bodied person
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy men and women whose most recent health check results show that their glucose metabolism is in the high normal range (fasting blood glucose level is 100-125mg/dL or HbA1c is 5.6-6.4%) 2) Subjects who have been fully informed of the purpose and content of the study and have voluntarily agreed to participate in writing
Exclusion criteria
Exclusion criteria: 1) Those currently undergoing treatment for or with a history of malignant tumors, heart failure, or myocardial infarction 2) Those with a pacemaker or implantable cardioverter defibrillator 3) Those currently undergoing treatment for the following chronic diseases: arrhythmia, liver disorder, kidney disorder, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, and other chronic diseases 4) Those who plan to take medicines, over-the-counter medicines (OTC), herbal medicines, health foods, and supplements, including foods for specified health uses and foods with functional claims, that may affect the study during the study period 5) Those with allergies (to medicines or research-related foods) 6) Those who are pregnant, breastfeeding, or intend to become pregnant during the study period 7) Individuals who have participated in other clinical trials within one month prior to obtaining the consent form, or who are scheduled to participate in other clinical trials during the study period. 8) Individuals who are otherwise deemed inappropriate by the study director to be subjects of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Vascular endothelial function | — |
Countries
Japan
Contacts
Macromill, Inc. Life Science Division